The neurooncology research group of IDIBELL, Bellvitge University Hospital and the ICO has described in a study published in the prestigious journal JAMA Neurology two different clinical patterns of encephalitis that occur as a side effect of a cancer treatment with immunotherapy.
A study by Bellvitge Hospital establishes, for the first time, a temporary criterion for the risk of chronicity of symptoms for the different subtypes of ADD.
Some 400,000 people, mostly young people and teenagers, currently suffer from some type of ADD in Spain.
The patient, who underwent robotic surgery, returned home the same day of the intervention.
This case is the starting point of a program that hopes to include around 40 patients annually.
Collaboration between the Intensive Care Medicine and Pulmonology services has made it possible to treat a patient with alveolar proteinosis who could receive a lung transplant